149 related articles for article (PubMed ID: 6195962)
1. [Characteristics of 57Co-bleomycetin accumulation in the primary tumor and in its metastases to the lungs in mice with Lewis carcinoma].
Vatin OE; Petriev VM; Prusova RM
Antibiotiki; 1983 Sep; 28(9):686-9. PubMed ID: 6195962
[TBL] [Abstract][Full Text] [Related]
2. [57Co-bleomycetin pharmacokinetics in the body of mice with LIO-1 lymphosarcoma].
Petriev VM; Vatin AE; Prusova RM; Filatov PP; Khachirov DG
Antibiotiki; 1982 Aug; 27(8):623-6. PubMed ID: 6181732
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of 57Co-bleomycin A5 in the body of animals with various inoculated tumors].
Petriev VM; Chacirov DG; Prusova RM
Radiobiol Radiother (Berl); 1983; 24(6):769-77. PubMed ID: 6199810
[No Abstract] [Full Text] [Related]
4. 51Cr-bleomycin, a new oncophilic radiopharmaceutical. I. Activity concentrations in transplantable tumours and organs-tissues of mice.
Rembelska MJ; Liniecki J
Nuklearmedizin; 1982 Apr; 21(2):62-7. PubMed ID: 6179045
[TBL] [Abstract][Full Text] [Related]
5. [Experimental basis for the diagnostic use of bleomycetin-57Co].
Khachirov DG; Petriev VM; Matveenko EG; Prusova RM
Med Radiol (Mosk); 1980 Jun; 25(6):22-7. PubMed ID: 6156371
[No Abstract] [Full Text] [Related]
6. [Comparative studies on the uptake and organ distribution of 57Co-bleomycin and 57Co-bleomycin-A2 in mice with squamous cell tumors of the skin and vagina].
Pertynski T; Ketkar MB; Mariss P; Reznik G; Talas A; Dieffenbach G
Nuklearmedizin; 1979; 18(6):300-3. PubMed ID: 94162
[No Abstract] [Full Text] [Related]
7. [57Co-bleomycetin distribution in the body of experimental animals with hyperglycemia].
Ul'ianenko SE; Petriev VM; Dedenkov AN
Antibiot Med Biotekhnol; 1987 Jul; 32(7):517-20. PubMed ID: 2445278
[TBL] [Abstract][Full Text] [Related]
8. Intracellular distribution of 57Co-bleomycin.
Konings AW; Rasker JJ; Posthuma GA
Curr Top Radiat Res Q; 1978 Jan; 12(1-4):497-512. PubMed ID: 76527
[TBL] [Abstract][Full Text] [Related]
9. DNA interaction with 57Co-bleomycin.
Kakinuma J; Orii H
Nuklearmedizin; 1982 Dec; 21(6):232-5. PubMed ID: 6188112
[TBL] [Abstract][Full Text] [Related]
10. Comparison of uptake of 67Ga-citrate and 57Co-bleomycin in tumor using a semiconductor detector.
Higashi T; Kanno M; Tomura K
J Nucl Med; 1974 Dec; 15(12):1167-70. PubMed ID: 4139249
[No Abstract] [Full Text] [Related]
11. The influence of chemotherapy on the distribution of 57Co-bleomycin in chemically induced squamous cell carcinoma of mouse skin.
Pertynski T; Reznik G; Mariss P; Ketkar MB; Haindl H; Dieffenbach G
Eur J Nucl Med; 1979 Feb; 4(1):55-9. PubMed ID: 91511
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of 57Co-bleomycin delivery to brain metastases and their tumors of origin.
Front D; Even-Sapir E; Iosilevsky G; Israel O; Frenkel A; Kolodny GM; Feinsud M
J Neurosurg; 1987 Oct; 67(4):506-10. PubMed ID: 2443624
[TBL] [Abstract][Full Text] [Related]
13. The effect of dose loading and of double labelling with 57Co and 125I on the tissue distribution in animals.
Vos CM; Westera G; van der Jagt PJ; van Zanten B
Eur J Nucl Med; 1979 Oct; 4(5):393-6. PubMed ID: 93048
[TBL] [Abstract][Full Text] [Related]
14. [Influence of radiotherapy upon tumor accumulation and organ distribution of 57Co-bleomycin in mice with chemically induced squamous cell carcinoma (author's transl)].
Pertynski T; Ketkar MB; Mariss P; Reznik G; Hassenstein E; Nüsslin F; Dieffenbach G; Haindl H
Strahlentherapie; 1979 Nov; 155(11):770-3. PubMed ID: 92831
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of local in vivo application of bleomycetin (bleomycin), chemosorbed on ion exchange medical gauze].
Tikhomirov GA; Bukhman VM; Prigozhina MM; Ryltsev VV; Filatov VN
Antibiot Khimioter; 1995 Jun; 40(6):19-22. PubMed ID: 8593089
[TBL] [Abstract][Full Text] [Related]
16. [Positive tumor scintigraphy. I. Pharmacokinetics of 111In and 57Co bleomycin].
Blottner A; Deckart H; Weiland J
Radiobiol Radiother (Berl); 1978 Jun; 19(3):365-77. PubMed ID: 82976
[No Abstract] [Full Text] [Related]
17. 57Co-bleomycin kinetics in normal and tumour-bearing mice after systemic and local administration.
Bier J; Benders P; Bitter K; Wenzel M
J Maxillofac Surg; 1979 Feb; 7(1):32-40. PubMed ID: 86593
[TBL] [Abstract][Full Text] [Related]
18. [A substance with affinity for malignant cancer, 57Co-bleomycin].
Kono A; Kojima M; Maeda T
Rinsho Hoshasen; 1973 Mar; 18(3):195-6. PubMed ID: 4122814
[No Abstract] [Full Text] [Related]
19. Disposition of the pulmonary toxin, bleomycin.
Tom WM; Montgomery MR
Drug Metab Dispos; 1979; 7(2):90-3. PubMed ID: 89025
[TBL] [Abstract][Full Text] [Related]
20. [Effect of 57Co-bleomycetin on the immune response induced in mice by ram erythrocytes].
Vatin AE; Petriev VM; Filatov PP
Antibiotiki; 1980 Jun; 25(6):458-60. PubMed ID: 6156640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
